Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-01-21

Clinical Trial Update: A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma [NA]

View source ↗

Summary

This is an update on a glioblastoma clinical trial evaluating bevacizumab combined with conventional therapy; the study's phase and status are currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Glioblastoma | NA | Status: UNKNOWN